Abstract
Overactive bladder (OAB) is a common condition that affects many adults, and prevalence increases with age in both men and women. It is characterized by symptoms of urinary frequency and urgency with or without urge incontinence in the absence of another proven etiology. As a diagnosis based solely on urinary symptoms, proper evaluation of OAB often depends on the use of psychometrically validated questionnaires to assess symptom severity and degree of bother. General urinary assessment forms can evaluate many urinary symptoms while modular questionnaires can focus on the most bothersome complaints. Many questionnaires have been formulated and validated to achieve these goals. Currently, the ideal questionnaire does not exist. This review attempts to outline the range of questionnaires available to the clinician to assist in evaluating symptoms as well as degree of impact on quality of life.
Similar content being viewed by others
References
Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–14. discussion 14-5.
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36.
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78.
Tubaro A, Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol. 2005;17:507–11.
Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–6.
Donovan J, Bosch R, Gotoh M, et al. Symptom and quality of life assessment. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence: Proceedings of the Third International Consultation on Incontinence, June 26–29, 2004. 3rd ed. Plymouth: Health Publication; 2005. p. 519–84.
Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Control Clin Trials. 1989;10:S195.
Avery KN, Bosch JL, Gotoh M, et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol. 2007;177(1):39–49.
Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol. 2001;166(2):550–2.
Khan MS, Chaliha C, Leskova L, et al. The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration. BJOG. 2004;111(5):468–74.
Albo M, Wruck L, Baker J, et al. The relationships among measures of incontinence severity in women undergoing surgery for stress urinary incontinence. J Urol. 2007;177(5):1810–4.
On SJ, Ku JH. Comparative study of international prostate symptom scores and urodynamic parameters in men and women with lower urinary tract symptoms. Urol Int. 2006;76(4):309–13.
Fayers P, de Haes J. Quality of life and clinical trials. Lancet. 1995;346:1.
Penson DF, Litwin MS. Quality of life assessment in urology. Contemp Urol. 1997;9:53–66.
Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835–40.
Kelly CE. Which questionnaires should be used in female urology practice? Curr Urol Rep. 2003;4(5):375–80.
Lepor H, Machi G. Comparison of AUA Symptom Index in unselected males and females between fifty-five and seventy-nine years of age. Urology. 1993;42:36–41.
Chai TC, Belville WD, McGuire EJ, et al. Specificity of the American Urological Association Voiding Symptom Index: comparison of unselected and selected samples of both sexes. J Urol. 1993;150:1710–3.
Scarpero HM, Fiske J, Nitti VW. The American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life [Abstract]. J Urol. 2002;167:76.
Shumaker SA, Wyman JF, Uebersax JS, et al. Health-related quality of life measures for women with urinary incontinence: the urogenital distress inventory and the incontinence impact questionnaire. Quality Life Res. 1994;3:291–306.
Hagen S, Hanley J, Capewell A. Test-retest reliability, validity, and sensitivity to change of the urogenital distress inventory and the incontinence impact questionnaire. Neurourol Urodyn. 2002;21(6):534–9.
Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14(2):131–9.
Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms Questionnaires: development and psychometric testing. Br J Urol. 1996;7:805–12.
Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563–74.
Matza LS, Thompson CL, Krasnow J, et al. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn. 2005;24(3):215–25.
Coyne KS, Schmier J, Hunt T, et al. Developing a specific HRQL instrument for overactive bladder. Value Health. 2000;3:141.
Coyne K, Matza LS, Versi E. Urinary urgency: Can “gotta go” be measured? Poster presented at the 10th Annual Meeting of the International Society for Quality of Life Research, Prague, Czech Republic, 2003.
Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. N Engl J Med. 1996;334:1441–7.
Piault E, Evans CJ, Espindle D, et al. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn. 2008;27(3):179–90.
Donovan J, Naughton M, Gotoh M, et al. Symptom and quality of life assessment. In: Khoury S, Wein A, editors. Incontinence: Proceedings of the First International Consultation on Incontinence, June 28 – July 1, 1998 Plymouth. UK: Health Publication; 1999. p. 295–331.
Donovan J, Badia X, Corcos J, et al. Symptom and quality of life assessment. In: Cardozo L, Khoury S, Wein A, editors. Incontinence: Proceedings of the Second International Consultation on Incontinence, July 1-3, 2001. 2nd ed. Plymouth: Health Publication; 2002. p. 267–316.
Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.
Abrams P, Avery K, Gardener N, et al. The international consultation on incontinence modular questionnaire: www.iciq.net. J Urol. 2006;175(3 Pt 1):1063-6; discussion 1066.
Donovan JK, Abrams P, Peters TJ, et al. The ICS-‘BPH’ study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996;77:554.
Disclosure
No potential conflicts of interest related to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shy, M., Fletcher, S.G. Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?. Curr Bladder Dysfunct Rep 8, 45–50 (2013). https://doi.org/10.1007/s11884-012-0167-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-012-0167-2